Agios Pharmaceuticals | 販売および管理費





販売および管理費 変化する 日付
AbbVie USD 3.25B 40M 2025-06
Agios Pharmaceuticals USD 41.27M 4.6M 2025-09
Alnylam Pharmaceuticals USD 262.59M 60.72M 2025-09
Amgen USD 1.7B 9M 2025-09
Arrowhead Research USD 37.18M 6.23M 2025-09
Astellas Pharma JPY 206.84B 9.84B 2025-09
AstraZeneca USD 148M 4.86B 2025-09
Bayer EUR 3.4B 140M 2025-09
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Bristol-Myers Squibb USD 1.79B 76M 2025-09
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Eli Lilly USD 2.74B 12.3M 2025-09
Exelixis USD 103.13M 9.8M 2025-09
Gilead Sciences USD 1.35B 6M 2025-09
GlaxoSmithKline GBP 2.16B 19M 2025-09
Incyte USD 329.08M 1.94M 2025-09
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
Merck USD 2.63B 0 2025-09
Moderna USD 268M 38M 2025-09
Novartis USD 3.31B 134M 2025-09
Novartis USD 3.3B 137M 2025-09
Pfizer USD 3.19B 209M 2025-09
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
Vertex Pharmaceuticals USD 445.1M 20.5M 2025-09


Agios Pharmaceuticals 販売および管理費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.